Clinical Trials Directory

Trials / Completed

CompletedNCT02835859

Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
AdventHealth Translational Research Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to collect data that will help researchers better understand the various causes of obesity and diabetes; particularly to understand how consumption of NCASs affects the way the body uses nutrients.

Conditions

Interventions

TypeNameDescription
OTHERDietary: saccharinAssess the glycemic and hormonal responses to an oral glucose load preceded by an oral solution of NCASs (saccharin).
OTHEREstimate glucose absorptionsIndirectly estimate the rate of glucose absorption and gastric emptying by using 3-O-methyglucose (3-OMG) and acetaminophen, respectively.

Timeline

Start date
2014-08-01
Primary completion
2016-01-01
Completion
2017-09-01
First posted
2016-07-18
Last updated
2020-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02835859. Inclusion in this directory is not an endorsement.

Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners (NCT02835859) · Clinical Trials Directory